A study to evaluate the disposition of drug in body and safety after administration of single inhaled doses of drugs Abediterol and AZD7594 administered alone, in fixed dose combination and in free combination using the dry powder inhaler in healthy male participants

Trial Identifier: D7110C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT02967159
Start Date: November 2016
Primary Completion Date: April 2017
Study Completion Date: April 2017
Condition: Asthma; Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English translation
German translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050